Pentech

Pentech is a UK-based venture firm, established as Pentech Ventures, with a long history of backing European software and technology companies from seed and Series A, particularly across the UK and broader European ecosystem. The source data carries no explicit healthcare thesis, but Pentech’s general profile suggests selective participation in healthcare technology, B2B SaaS targeting healthcare buyers, and AI-enabled enterprise software where healthcare is one of several end markets. Check sizes are typically in the GBP 1M to GBP 5M range at initial investment, with capacity to lead UK seed and Series A rounds and meaningful reserves for follow-on. For healthcare founders, Pentech is most relevant if you are a UK or European software company whose end customer is in healthcare but whose underlying product playbook is enterprise software or AI infrastructure rather than clinical or regulated medical technology. The firm is a poor fit for therapeutics, regulated devices, diagnostics, US-only commercial-stage businesses and any company requiring deep healthcare-specific operating expertise from the investor. Founders should expect financial-led diligence with strong emphasis on team, ARR economics, retention and capital efficiency. Entry is best via warm introductions from UK-based founders in the Pentech portfolio, fellow VCs in European software, or via LinkedIn outreach to investment partners. Cold outbound is workable but should lead with a tight commercial story rather than healthcare narrative. Confirm current fund stage, geographic mandate, healthcare exposure in the existing portfolio, and lead capacity in any first conversation.